Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor
Gespeichert in:
| Veröffentlicht in: | Eye (London) 2018-09, Vol.32 (9), p.1544-1546 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1546 |
|---|---|
| container_issue | 9 |
| container_start_page | 1544 |
| container_title | Eye (London) |
| container_volume | 32 |
| creator | Nguyen, Ngoc Chau Isabelle Fabro, Filippo Ambresin, Aude Ezziat, Sakina Bergin, Ciara Mazzocato, Claudia Mantel, Irmela |
| description | |
| doi_str_mv | 10.1038/s41433-018-0126-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6137149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2040762487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-e342cf1732c8b6cd7ac88d4aa678a60841df6142f64665e59b289cf4c09be1143</originalsourceid><addsrcrecordid>eNp1kUFrHCEUx6U0NNu0H6CXMpBLL5M8HUedSyCEpi0EcmmhN3GdN7sus7pVZ0Py6eNm0zQJ9CAi7-ff9_wR8onCCYVGnSZOedPUQFVZTNR3b8iMcinqlrf8LZlB10LNGPt9SN6ntAIoRQnvyCHrpOhECzOCl8bmEFNlUgrWmYx9dePystoY56t-is4vKudzNFuXI5qxHFZoswu-CkNlfHb11iQ7jSZW6PuQlzi6gi1iuCkxw0P8B3IwmDHhx8f9iPy6_Prz4nt9df3tx8X5VW25hFxjw5kdqGyYVXNhe2msUj03RkhlBChO-0FQzgbBhWix7eZMdXbgFro50vIXR-Rsn7uZ5mvsLe4aH_UmurWJtzoYp19WvFvqRdhqQRtJeVcCvjwGxPBnwpT12iWL42g8hilpBhykYFzJgh6_Qldhir6Mp1mxI9oOAApF95SNIaWIw1MzFPROot5L1EWi3knUd-XO5-dTPN34a60AbA-kzc4Pxn9P_z_1Hg8Kqo8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2103659000</pqid></control><display><type>article</type><title>Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Nguyen, Ngoc Chau Isabelle ; Fabro, Filippo ; Ambresin, Aude ; Ezziat, Sakina ; Bergin, Ciara ; Mazzocato, Claudia ; Mantel, Irmela</creator><creatorcontrib>Nguyen, Ngoc Chau Isabelle ; Fabro, Filippo ; Ambresin, Aude ; Ezziat, Sakina ; Bergin, Ciara ; Mazzocato, Claudia ; Mantel, Irmela</creatorcontrib><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/s41433-018-0126-z</identifier><identifier>PMID: 29769650</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject><![CDATA[692/1807/410 ; 692/700/784 ; Adult ; Angiogenesis Inhibitors - administration & dosage ; Bevacizumab - administration & dosage ; Correspondence ; Eye Pain - etiology ; Humans ; Intravitreal Injections - adverse effects ; Laboratory Medicine ; Medicine ; Medicine & Public Health ; Ophthalmology ; Pain ; Pharmaceutical Sciences/Technology ; Ranibizumab - administration & dosage ; Receptors, Vascular Endothelial Growth Factor - administration & dosage ; Recombinant Fusion Proteins - administration & dosage ; Retinal Diseases - drug therapy ; Risk Factors ; Surgery ; Surgical Oncology ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - antagonists & inhibitors]]></subject><ispartof>Eye (London), 2018-09, Vol.32 (9), p.1544-1546</ispartof><rights>The Royal College of Ophthalmologists 2018</rights><rights>Copyright Nature Publishing Group Sep 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-e342cf1732c8b6cd7ac88d4aa678a60841df6142f64665e59b289cf4c09be1143</citedby><cites>FETCH-LOGICAL-c470t-e342cf1732c8b6cd7ac88d4aa678a60841df6142f64665e59b289cf4c09be1143</cites><orcidid>0000-0002-8822-8194</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137149/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137149/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,41486,42555,51317,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29769650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Ngoc Chau Isabelle</creatorcontrib><creatorcontrib>Fabro, Filippo</creatorcontrib><creatorcontrib>Ambresin, Aude</creatorcontrib><creatorcontrib>Ezziat, Sakina</creatorcontrib><creatorcontrib>Bergin, Ciara</creatorcontrib><creatorcontrib>Mazzocato, Claudia</creatorcontrib><creatorcontrib>Mantel, Irmela</creatorcontrib><title>Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><subject>692/1807/410</subject><subject>692/700/784</subject><subject>Adult</subject><subject>Angiogenesis Inhibitors - administration & dosage</subject><subject>Bevacizumab - administration & dosage</subject><subject>Correspondence</subject><subject>Eye Pain - etiology</subject><subject>Humans</subject><subject>Intravitreal Injections - adverse effects</subject><subject>Laboratory Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Ophthalmology</subject><subject>Pain</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Ranibizumab - administration & dosage</subject><subject>Receptors, Vascular Endothelial Growth Factor - administration & dosage</subject><subject>Recombinant Fusion Proteins - administration & dosage</subject><subject>Retinal Diseases - drug therapy</subject><subject>Risk Factors</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUFrHCEUx6U0NNu0H6CXMpBLL5M8HUedSyCEpi0EcmmhN3GdN7sus7pVZ0Py6eNm0zQJ9CAi7-ff9_wR8onCCYVGnSZOedPUQFVZTNR3b8iMcinqlrf8LZlB10LNGPt9SN6ntAIoRQnvyCHrpOhECzOCl8bmEFNlUgrWmYx9dePystoY56t-is4vKudzNFuXI5qxHFZoswu-CkNlfHb11iQ7jSZW6PuQlzi6gi1iuCkxw0P8B3IwmDHhx8f9iPy6_Prz4nt9df3tx8X5VW25hFxjw5kdqGyYVXNhe2msUj03RkhlBChO-0FQzgbBhWix7eZMdXbgFro50vIXR-Rsn7uZ5mvsLe4aH_UmurWJtzoYp19WvFvqRdhqQRtJeVcCvjwGxPBnwpT12iWL42g8hilpBhykYFzJgh6_Qldhir6Mp1mxI9oOAApF95SNIaWIw1MzFPROot5L1EWi3knUd-XO5-dTPN34a60AbA-kzc4Pxn9P_z_1Hg8Kqo8</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Nguyen, Ngoc Chau Isabelle</creator><creator>Fabro, Filippo</creator><creator>Ambresin, Aude</creator><creator>Ezziat, Sakina</creator><creator>Bergin, Ciara</creator><creator>Mazzocato, Claudia</creator><creator>Mantel, Irmela</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8822-8194</orcidid></search><sort><creationdate>20180901</creationdate><title>Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor</title><author>Nguyen, Ngoc Chau Isabelle ; Fabro, Filippo ; Ambresin, Aude ; Ezziat, Sakina ; Bergin, Ciara ; Mazzocato, Claudia ; Mantel, Irmela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-e342cf1732c8b6cd7ac88d4aa678a60841df6142f64665e59b289cf4c09be1143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>692/1807/410</topic><topic>692/700/784</topic><topic>Adult</topic><topic>Angiogenesis Inhibitors - administration & dosage</topic><topic>Bevacizumab - administration & dosage</topic><topic>Correspondence</topic><topic>Eye Pain - etiology</topic><topic>Humans</topic><topic>Intravitreal Injections - adverse effects</topic><topic>Laboratory Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Ophthalmology</topic><topic>Pain</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Ranibizumab - administration & dosage</topic><topic>Receptors, Vascular Endothelial Growth Factor - administration & dosage</topic><topic>Recombinant Fusion Proteins - administration & dosage</topic><topic>Retinal Diseases - drug therapy</topic><topic>Risk Factors</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Ngoc Chau Isabelle</creatorcontrib><creatorcontrib>Fabro, Filippo</creatorcontrib><creatorcontrib>Ambresin, Aude</creatorcontrib><creatorcontrib>Ezziat, Sakina</creatorcontrib><creatorcontrib>Bergin, Ciara</creatorcontrib><creatorcontrib>Mazzocato, Claudia</creatorcontrib><creatorcontrib>Mantel, Irmela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Ngoc Chau Isabelle</au><au>Fabro, Filippo</au><au>Ambresin, Aude</au><au>Ezziat, Sakina</au><au>Bergin, Ciara</au><au>Mazzocato, Claudia</au><au>Mantel, Irmela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>32</volume><issue>9</issue><spage>1544</spage><epage>1546</epage><pages>1544-1546</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29769650</pmid><doi>10.1038/s41433-018-0126-z</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-8822-8194</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-222X |
| ispartof | Eye (London), 2018-09, Vol.32 (9), p.1544-1546 |
| issn | 0950-222X 1476-5454 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6137149 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | 692/1807/410 692/700/784 Adult Angiogenesis Inhibitors - administration & dosage Bevacizumab - administration & dosage Correspondence Eye Pain - etiology Humans Intravitreal Injections - adverse effects Laboratory Medicine Medicine Medicine & Public Health Ophthalmology Pain Pharmaceutical Sciences/Technology Ranibizumab - administration & dosage Receptors, Vascular Endothelial Growth Factor - administration & dosage Recombinant Fusion Proteins - administration & dosage Retinal Diseases - drug therapy Risk Factors Surgery Surgical Oncology Vascular endothelial growth factor Vascular Endothelial Growth Factor A - antagonists & inhibitors |
| title | Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A17%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20pain%20during%20intravitreal%20injection%20of%20anti-vascular%20endothelial%20growth%20factor&rft.jtitle=Eye%20(London)&rft.au=Nguyen,%20Ngoc%20Chau%20Isabelle&rft.date=2018-09-01&rft.volume=32&rft.issue=9&rft.spage=1544&rft.epage=1546&rft.pages=1544-1546&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/s41433-018-0126-z&rft_dat=%3Cproquest_pubme%3E2040762487%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2103659000&rft_id=info:pmid/29769650&rfr_iscdi=true |